Incisive Surgical receives U.S. patent for INSORB Absorbable Skin Stapling Technology

Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) issued the Company a key patent for its proprietary INSORB® Absorbable Skin Stapling Technology.  The allowed claims include comprehensive subject matter covering the method and apparatus of the INSORB Skin Closure technology.  The Company also announced that it has received a notice of allowance of patent issuance from the USPTO relating to the absorbable staple.  In addition, the Company announced that the Japanese Patent Office issued a notice of allowance of patent issuance covering the method and apparatus of the INSORB Technology.  The Company was issued a Japanese patent in 2010 relating to its absorbable staple.  The INSORB Absorbable Skin Stapling Technology is a revolutionary new surgical modality that places an absorbable staple entirely underneath the skin to close surgical incisions.  Patients now have a more comfortable, convenient and cosmetic choice for rapid skin closure.  This unique device has won several national awards, including the 2006 Wall Street Journal Technology Innovation of the Year Award for medical devices.    Incisive Surgical is the only company in the world that offers this technology and has sold over 650,000 INSORB® Absorbable Skin Staplers since the product launch in January 2005.  

"Incisive Surgical will soon hold eight INSORB Patents throughout the world," said John L. Shannon, Jr., president and chief executive officer of Incisive Surgical.  "We have patents covering all three essential core elements of the INSORB Technology – the method, the absorbable staple, and the mechanical stapler.   This is further recognition of the significant technological advance for the benefit of patients, clinicians and health care facilities, as well as the ingenuity of our development team and the novelty of the INSORB Technology."